Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LivaNova PLCLIVN · Entity 507 | Director | September 04, 2026 | September 08, 2026 |
| PolyPid Ltd.PYPD · Entity 6713 | Director | July 15, 2026 | July 17, 2026 |
| Sigilon Therapeutics, Inc.SGTX · Entity 11481 | Director | May 26, 2022 | May 27, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LivaNova PLC
Report date September 04, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 7,488 |
Reported balance
After 2026-09-04 transaction · row 1
1 source rowRow 1 · 2026-09-04 · Sale · Disposed 2,300 · Balance 7,488 |
PolyPid Ltd.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.46 · Expires 2036-07-15 | Direct | 9,132 |
Reported balance
After 2026-07-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 9,132 · Balance 9,132 F1: The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030.
Sigilon Therapeutics, Inc.
Report date May 26, 2022 · Filed May 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.76 · Expires 2032-05-25 | Direct | 8,888 |
Reported balance
After 2022-05-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-26 · Grant · Acquired 8,888 · Balance 8,888 F1: The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on May 26, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on May 26, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 8, 2026 21:01 UTC | LivaNova PLC LIVN · Entity 507 | SaleOrdinary Shares | 2,300 | $81.42 | $187,270.14 |
DisclosureSEC source: 0001639691-26-000102 · wk-form4_1788901306.xml · nonDerivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,488 Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:01 UTC | PolyPid Ltd. PYPD · Entity 6713 | GrantStock option (right to buy) · Derivative | 9,132 | $4.46 Strike: $4.46 | $40,728.72 |
DisclosureSEC source: 0001213900-26-079148 · ownership.xml · derivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,132 Underlying: Ordinary Shares · 9,132 shares Expires 2036-07-15 F1 · derivative.exercise_date: The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:08 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000068 · wk-form4_1781726926.xml · derivative · entry 4 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,383 Underlying: Ordinary Shares · 2,383 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F5 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F5 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:08 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000068 · wk-form4_1781726926.xml · derivative · entry 3 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026. F4 · derivative.expiration_date: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:08 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 486 | $79.70 | $38,734.20 |
DisclosureSEC source: 0001639691-26-000068 · wk-form4_1781726926.xml · nonDerivative · entry 2 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,788 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:08 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000068 · wk-form4_1781726926.xml · nonDerivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 20:57 UTC | LivaNova PLC LIVN · Entity 507 | SaleOrdinary Shares | 250 | $53.94 | $13,485.00 |
DisclosureSEC source: 0001639691-25-000154 · wk-form4_1763585818.xml · nonDerivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,232 Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · derivative · entry 4 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,042 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · derivative · entry 3 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 410 | $45.76 | $18,761.60 |
DisclosureSEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · nonDerivative · entry 2 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,482 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:54 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · nonDerivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · derivative · entry 4 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 Underlying: Ordinary Shares · 3,416 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F5 · derivative.exercise_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: The RSUs vest on June 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · derivative · entry 3 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. F4 · derivative.exercise_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. F4 · derivative.expiration_date: On June 15, 2023 the reporting person was granted RSUs vesting on June 15, 2024. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 584 | $52.68 | $30,765.12 |
DisclosureSEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · nonDerivative · entry 2 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,476 F3 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:05 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000091 · wk-form4_1718741098.xml · nonDerivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") settled into ordinary shares of LivaNova PLC ("the Company"), GBP 1.00 par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Company's 2015 Incentive Award Plan ("the Plan") and the award agreement. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 21:08 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-23-000084 · wf-form4_169515771652179.xml · derivative · entry 3 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,725 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F4 · derivative.exercise_date: On September 15, 2022, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on September 15, 2023, subject to continued service during the vesting period and the award agreement. F4 · derivative.expiration_date: On September 15, 2022, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on September 15, 2023, subject to continued service during the vesting period and the award agreement. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 21:08 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 345 | $57.80 | $19,941.00 |
DisclosureSEC source: 0001639691-23-000084 · wf-form4_169515771652179.xml · nonDerivative · entry 2 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,380 F2 · shares: The referenced shares were withheld from distribution to satisfy tax liability. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 21:08 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-23-000084 · wf-form4_169515771652179.xml · nonDerivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 19:35 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-23-000065 · wf-form4_168728968803531.xml · derivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,680 Underlying: Ordinary Shares · 2,680 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F2 · derivative.exercise_date: On June 15, 2023, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2024, subject to continued service during the vesting period and the award agreement. F2 · derivative.expiration_date: On June 15, 2023, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2024, subject to continued service during the vesting period and the award agreement. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 20:56 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-22-000091 · wf-form4_166362099620948.xml · derivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Underlying: Ordinary Shares · 1,725 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F2 · derivative.exercise_date: Reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on the earliest of (i) September 15, 2023, (ii) the date of a change in control or (iii) a termination of service in accordance with the RSU Agreement. F2 · derivative.expiration_date: Reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on the earliest of (i) September 15, 2023, (ii) the date of a change in control or (iii) a termination of service in accordance with the RSU Agreement. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:00 UTC | Sigilon Therapeutics, Inc. SGTX · Entity 11481 | GrantStock Option (Right to Buy) · Derivative | 8,888 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001415889-22-005825 · form4-05272022_050501.xml · derivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Common Stock · 8,888 shares Expires 2032-05-25 F1 · derivative.exercise_date: The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on May 26, 2023. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:10 UTC | Sigilon Therapeutics, Inc. SGTX · Entity 11481 | GrantStock Option (Right to Buy) · Derivative | 17,777 | $0.00 Strike: $11.19 | $0.00 |
DisclosureSEC source: 0001415889-21-003033 · form4-06162021_040601.xml · derivative · entry 1 Story Brooke · CIK 0001866136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,777 Underlying: Common Stock · 17,777 shares Expires 2031-06-13 F1 · derivative.exercise_date: The option vest as to one-third of the shares on each of June 14, 2022, June 14, 2023 and June 14, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.